Metabolomics,Multiomics

Dataset Information

0

Gut Microbial and Metabolic Responses to Salmonella enterica Serovar Typhimurium and Candida albicans


ABSTRACT:

The gut microbiota is increasingly recognized for playing a critical role in human health and disease, especially in conferring resistance to both virulent pathogens such as Salmonella, which infects 1.2 million people in the United States every year [1], and opportunistic pathogens like Candida, which causes an estimated 46,000 cases of invasive candidiasis each year in the United States [2]. The dynamics of pathogen-microbiome interactions and the metabolites involved in this process remain largely unknown.

We use gnotobiotic mice infected with the virulent pathogen Salmonella enterica serovar Typhimurium or the opportunistic pathogen Candida albicans in combination with metagenomics and discovery metabolomics to identify changes in the community and metabolome during infection. To isolate the role of the microbiota in response to pathogens, we compared mice monocolonized with the pathogen, uninfected mice 'humanized' with a synthetic human microbiome, or infected humanized mice. We observe that changes in the community and in biosynthetic gene cluster potential occur within 3 days for the virulent Salmonella enterica serovar Typhimurium, but there are minimal changes with a poorly colonizing Candida albicans. In addition, the metabolome shifts depending on infection status, including changes in glutathione metabolites in response to Salmonella infection. The LC-MS metabolomic fingerprint of the cecum differed between mice monocolonized with either pathogen and humanized infected mice. Specifically, we identified an increase in glutathione disulfide, glutathione cysteine disulfide, inosine 5'-monophosphate, and hydroxybutyrylcarnitine in mice infected with Salmonella in contrast to uninfected mice and mice monocolonized with Salmonella. These metabolites potentially play a role in pathogen-induced oxidative stress. These results provide insight into how the microbiota community members interact with each other and with pathogens on a metabolic level.


Ref:

[1] Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, and Griffin PM. Foodborne Illness Acquired in the United States—Major Pathogens. Emerg Infect Dis 2011;17:7-15. doi.org/10.3201/eid1701.P11101

[2] Centers for Disease Control and Prevention, Antibiotic Resistance Threats in the United States, 2013

INSTRUMENT(S): Liquid Chromatography Tandem MS (LC-MS/MS), Liquid Chromatography MS - Positive (LC-MS (Positive))

SUBMITTER: Caitlin Keller 

PROVIDER: MTBLS753 | MetaboLights | 2019-09-20

REPOSITORIES: MetaboLights

altmetric image

Publications

Gut Microbial and Metabolic Responses to Salmonella enterica Serovar Typhimurium and Candida albicans.

Bratburd Jennifer R JR   Keller Caitlin C   Vivas Eugenio E   Gemperline Erin E   Li Lingjun L   Rey Federico E FE   Currie Cameron R CR  

mBio 20181106 6


The gut microbiota confers resistance to pathogens of the intestinal ecosystem, yet the dynamics of pathogen-microbiome interactions and the metabolites involved in this process remain largely unknown. Here, we use gnotobiotic mice infected with the virulent pathogen <i>Salmonella enterica</i> serovar Typhimurium or the opportunistic pathogen <i>Candida albicans</i> in combination with metagenomics and discovery metabolomics to identify changes in the community and metabolome during infection. T  ...[more]

Similar Datasets

2022-10-20 | GSE215880 | GEO
2016-09-14 | GSE79363 | GEO
2023-05-17 | GSE215053 | GEO
2021-04-16 | PXD018026 | Pride
2022-12-14 | GSE145862 | GEO
2015-09-01 | GSE40211 | GEO
2013-12-18 | GSE53406 | GEO
2014-07-23 | GSE59663 | GEO
2011-02-08 | E-GEOD-21720 | biostudies-arrayexpress
2015-09-01 | E-GEOD-40211 | biostudies-arrayexpress